Free testosterone is significantly more relevant to acne development than total testosterone. While total testosterone measures all androgens in your bloodstream—both the active form and the inactive, protein-bound form—free testosterone represents the biologically active hormone actually available to trigger acne-causing processes in your skin. Research shows this distinction matters: when researchers tested women with acne, they found elevated free testosterone in 11 out of 24 women, yet only 4 of those same women showed elevated total testosterone levels.
This means a standard testosterone test showing “normal” levels could be dangerously misleading if free testosterone isn’t measured separately. The reason free testosterone packs more acne potential than total testosterone comes down to a single protein: sex hormone-binding globulin (SHBG). In people with acne, SHBG is often abnormally low, which allows free testosterone to circulate unrestricted through the bloodstream and directly penetrate skin cells. This article breaks down the clinical science behind why free testosterone matters more, explains SHBG’s crucial role, and covers what you need to know if hormonal testing reveals imbalances—including why your doctor might recommend specific treatments even if your total testosterone appears normal.
Table of Contents
- Why Does Free Testosterone Matter More for Acne Than Total Testosterone?
- The SHBG Connection—Why Low SHBG Drives Acne in Some People
- How Testosterone Converts to DHT Inside Your Skin Cells
- Reading Your Testosterone Test Results—What “Normal” Actually Means
- Acne Risk in People Taking Testosterone Therapy
- Why Hormonal Contraceptives Work for Acne Despite Normal Testosterone Levels
- The Future of Testosterone-Related Acne Management
- Conclusion
Why Does Free Testosterone Matter More for Acne Than Total Testosterone?
Your blood doesn’t transport testosterone as a simple free molecule. Most testosterone (about 98%) binds tightly to proteins—primarily shbg and albumin—rendering it biochemically inactive. Only the unbound 1-2% remains free and bioavailable. For acne to develop, testosterone must be able to reach skin cells and trigger sebaceous gland activity and inflammatory responses. Free testosterone does this; bound testosterone cannot.
Clinical evidence underscores this distinction. A landmark study comparing testosterone profiles in women with and without acne found that elevated free testosterone was a more sensitive indicator of the hormonal imbalance driving acne than elevated total testosterone. This is why dermatologists increasingly order both measurements rather than relying on total testosterone alone. A person can have a “normal” total testosterone level while their free testosterone is elevated—and their acne worsens accordingly. Conversely, someone with a high total testosterone but high SHBG (which binds most of it) may experience little acne. The same total number masks vastly different acne risk depending on the free fraction.
The SHBG Connection—Why Low SHBG Drives Acne in Some People
Sex hormone-binding globulin functions as the body’s testosterone regulator. When SHBG is normal or high, it captures testosterone molecules and neutralizes their activity. When SHBG is low, testosterone remains free and circulates with direct access to skin cells. Research comparing acne patients to controls found significantly lower SHBG in the acne group, and this deficiency is remarkably common: approximately 54% of women with moderate to severe acne and 60% of women with acne plus hirsutism or irregular menstrual cycles showed clinically significant SHBG deficiency.
This matters because low SHBG can coexist with a normal total testosterone level. A woman might have a total testosterone count that appears unremarkable on paper, but if her SHBG is abnormally low, her free testosterone is 200 to 300 times more bioavailable than in someone with normal SHBG. That dramatic amplification effect explains why some acne sufferers see a profound difference when treatments target SHBG levels rather than total testosterone. However, not all acne is driven by hormonal imbalances—many people with acne have normal hormone levels entirely. SHBG-related acne appears more common in women than men and is often accompanied by other androgen-related symptoms like hirsutism, hair loss, or menstrual irregularities.
How Testosterone Converts to DHT Inside Your Skin Cells
Once free testosterone enters a skin cell, it faces an enzyme called 5-alpha reductase. This enzyme converts testosterone into dihydrotestosterone (DHT), a much more potent androgen with stronger binding affinity for androgen receptors in sebaceous glands and hair follicles. DHT is the form most directly responsible for increased sebum production, follicle hyperkeratinization (clogged pores), and the inflammatory cascade of acne. This enzymatic conversion happens directly in skin tissue, not in the bloodstream, which is why local free testosterone availability in the skin matters more than systemic total testosterone.
The 5-alpha reductase enzyme exists in higher concentrations in some individuals’ skin and in higher concentrations in facial and trunk skin compared to forearm skin—explaining why acne clusters on the face, chest, and back despite normal testosterone elsewhere on the body. Additionally, some people inherit genetic variants of the 5-alpha reductase enzyme that are more active, converting free testosterone to DHT more aggressively. This means two people with identical free testosterone levels could experience different acne severity if their enzyme activity differs. Environmental and dietary factors may also influence 5-alpha reductase activity, though research on this remains limited.
Reading Your Testosterone Test Results—What “Normal” Actually Means
If your doctor ordered testosterone testing, the report likely shows only total testosterone and possibly estradiol. Many labs don’t automatically measure free testosterone or SHBG, even though these are far more clinically relevant for acne. A total testosterone result of 40 ng/dL might be labeled “normal” by the lab’s reference range, yet if SHBG is low (normal range: 24-122 nmol/L), your free testosterone could still be elevated and acne-driving. Requesting the complete panel—total testosterone, free testosterone, and SHBG—gives a far clearer picture.
If your results show normal total testosterone but elevated free testosterone, or normal total testosterone with low SHBG, acne treatment targeting the free fraction (rather than trying to lower total testosterone) becomes more rational. Conversely, if both total and free testosterone are elevated, broader hormonal intervention may be needed. The Free Androgen Index (calculated as total testosterone divided by SHBG, then multiplied by 100) is sometimes used as a shorthand, but direct free testosterone measurement is more reliable. If your lab doesn’t offer free testosterone measurement, consider requesting a referral to an endocrinologist or a lab that specializes in hormone panels.
Acne Risk in People Taking Testosterone Therapy
People undergoing testosterone replacement therapy (TRT) or masculinizing hormone therapy sometimes develop or experience worsening acne. The incidence ranges widely from 0.6% to 10% depending on the testosterone formulation, dosing regimen, and the population studied. This variability likely reflects differences in individual sensitivity to androgens and baseline SHBG levels. Among those who do develop acne from testosterone therapy, onset typically peaks 6 to 12 months after starting treatment as free testosterone levels stabilize.
The mechanism is straightforward: exogenous testosterone supplementation raises total testosterone, and much of this circulates as free testosterone (especially in individuals with naturally low SHBG). Skin cells respond with increased sebum production and follicular inflammation. Managing acne in this context presents a genuine clinical challenge: stopping testosterone therapy may not be an option if it’s medically necessary for the patient’s wellbeing. Solutions include adjusting the testosterone dose or formulation, adding 5-alpha reductase inhibitors (like finasteride) to block DHT formation, or using conventional acne medications (topical retinoids, benzoyl peroxide, or antibiotics). However, some people on testosterone therapy never develop acne, suggesting individual skin sensitivity varies considerably.
Why Hormonal Contraceptives Work for Acne Despite Normal Testosterone Levels
Hormonal contraceptives effectively treat acne in many women not because they lower total testosterone, but because they increase SHBG. Estrogen (particularly ethinyl estradiol and newer bioidentical estrogens) stimulates hepatic SHBG production. When SHBG rises, more free testosterone gets trapped and inactivated, reducing the free androgen available to skin cells.
This mechanism explains why contraceptives can clear acne even in women with technically normal total testosterone levels—their acne was driven by low SHBG and high free testosterone, not by abnormally high total androgen production. Research comparing female acne patients to controls found that women with worse acne typically had significantly higher free testosterone and lower estradiol (often from progesterone-dominant pill choices or lower-estrogen formulations). Switching to a pill with higher estrogen content and lower androgenicity (progestin type matters considerably) can shift this balance. Spironolactone, an androgen receptor antagonist, offers another approach by blocking androgens’ effects directly in skin tissue without affecting hormonal levels—useful in women who cannot or prefer not to use hormonal contraception.
The Future of Testosterone-Related Acne Management
As understanding of free testosterone and SHBG deepens, acne treatment is becoming more personalized and rational. Rather than assuming all acne stems from elevated total testosterone and attempting broad hormonal suppression, forward-thinking dermatologists are increasingly ordering complete hormone panels to identify whether acne is truly androgen-driven or driven by other factors entirely. For those with documented free testosterone elevation or SHBG deficiency, targeted interventions—whether estrogen-based contraception, SHBG-boosting medications, or 5-alpha reductase inhibitors—offer a more precise approach than one-size-fits-all therapy.
Future research may also clarify why baseline SHBG and 5-alpha reductase activity vary so dramatically between individuals, and whether lifestyle modifications (diet, exercise, certain supplements) can meaningfully raise SHBG or reduce enzyme activity. For now, if you have persistent acne and hormonal testing is planned, request a full panel including free testosterone and SHBG. Understanding whether your acne is truly driven by androgen excess or by altered androgen availability due to SHBG deficiency fundamentally changes which treatments make sense to try first.
Conclusion
Free testosterone and total testosterone tell very different stories about acne risk. While total testosterone measures the full pool of hormone in your blood, free testosterone represents the biologically active form capable of triggering the cascade of sebum production, follicle inflammation, and DHT formation in skin cells. Because SHBG—the protein that regulates free testosterone—is often abnormally low in acne patients, many people develop acne despite “normal” total testosterone levels. A standard testosterone test alone will miss this imbalance entirely.
The practical takeaway: if you have acne and your doctor orders hormone testing, request a complete panel including free testosterone and SHBG levels. Treatment decisions should rest on the free testosterone result, not just the total. If your acne is confirmed to be androgen-related, understanding whether your issue stems from elevated androgens or from low SHBG will guide your doctor toward the most effective intervention—whether hormonal contraceptives to raise SHBG, 5-alpha reductase inhibitors to block DHT formation, or androgen receptor blockers. Personalized testing leads to more rational treatment choices and better outcomes.
